REDS (Respiratory Drugs Survey) Study. Active Surveillance of Respiratory Drugs and in Particular of Inhaled Steroids (IS) in the Paediatric Age
DOI:
https://doi.org/10.12974/2311-8687.2018.06.4Keywords:
Children, Adverse drug reactions, Inhaled steroids, Pharmacovigilance, Post-marketing clinical studies.Abstract
Background and aims: Inhaled Steroids (IS) are used inappropriately for children who have been "over prescribed" for conditions such as colds, coughs and sore throats. This practice is not always based on scientific evidence. IS have a modest effectiveness in preventing both recurrent wheezing, viral and bronchiolitis in children.
The aim of the study is to monitor the use of IS with careful analysis of the risk / benefit factor of the treatment, through accuracy of diagnosis, the therapeutic appropriateness and the safe use of these medications.
Methods: In this epidemiological / observational (case-study) and active observational project, the prescribing data for children (0-14 yrs) were collected and processed by Family Pediatricians (FPs). The activities have been divided into four sections:
1) Elaboration of the prescriptive data (year 2015-retrospective)
2) Training / information events for FPs and families on the correct use of IS (year 2016)
3) Elaboration of the prescriptive data of the same FPs after the training year (year 2017-prospective)
4) Comparison of the prescriptive data of IS in the age group of 0 - 14 years in the years 2015 and 2017 (before and after the training phase)
Results: After the training phase: the prevalence of use of IS decreased from 20.71% to 15.15% ; the percentage of the appropriate prescriptions increased from 30.65% to 58.02% ; the percentage of the inappropriate prescriptions decreased from 68.67 % to 38.66%; the prevalence of inappropriate prescriptions decreased : a) in the 0-4 yrs from 70.24% to 39.30%; b) in the 5-10 yrs from 66.31% to 35.95%, and c) in the 11-14 yrs from 69.80% to 35.04%; the percentage of inappropriate expenditure decreased from 67.31% to 37.63%; the percentages of inappropriate prescriptions decreased for Beclomethasone from 71.47% to 38.29%, for Budesonide from 69.82% to 43.29%, for Fluticasone from 53.84% to 19.01% and for Flunisolide from 70.45% to 56.93% ; the total number of pieces prescribed decreased from 4.338 to 3.148.
Conclusions: We have highlighted that through training courses for Family Pediatricians and a correct information to families a significant improvement in the use of Inhaled Steroids can be achieved.
References
OsMed Report 2017. The Use of Medicines in Italy. Medicines Utilization Monitoring Centre (OsMed). http://www.aifa.gov.it/sites/default/files/Rapporto_OsMed_20 17_AIFA.pdf
RFN-AIFA (2009). Drugs Information Bullettin 1: 1-4.
Napoleone E. “Children and ADRs (Adverse Drug Reactions) ”. Ital J Pediatr Jan 15, (2010); 36: 4 DOI: https://doi.org/10.1186/1824-7288-36-4
Kroegel C1.Global Initiative for Asthma Management and Prevention-GINA 2006. Pneumologie. 2007; 61(5): 295-304 DOI: https://doi.org/10.1055/s-2007-959180
Bateman ED1, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 Jan; 31(1): 143-78. DOI: https://doi.org/10.1183/09031936.00138707
Kroegel C1. Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol. 2009; 5(3): 239-49. https://doi.org/10.1586/eci.09.1 DOI: https://doi.org/10.1586/eci.09.1
Anderson-James S1, Marchant JM, Acworth JP, Turner C, Chang AB. Inhaled corticosteroids for subacute cough in children. Cochrane Database Syst Rev 2013; 28; 2: DOI: https://doi.org/10.1002/14651858.CD008888.pub2
Insel K, Lyon C. Clinical Inquiry: Are inhaled steroids effective for a postviral cough? J. Fam Pract. 2015; 64(3): 189
Clavenna A, Sequi M, Cartabia M, Fortinguerra F, Borghi M, Bonati M; ENBe Study Group. Effectiveness of nebulized beclomethasone in preventing viral wheezing: an RCT. Pediatrics. 2014; 133(3): e505-12. https://doi.org/10.1542/peds.2013-2404 DOI: https://doi.org/10.1542/peds.2013-2404
Doull IJ, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST.Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997; 4; 315(7112): 858-62 DOI: https://doi.org/10.1136/bmj.315.7112.858
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson DW, Klassen TP, Hartling L Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013 Jun 4; 6. https://doi.org/10.1002/14651858.CD004878.pub4 DOI: https://doi.org/10.1002/14651858.CD004878.pub4
Fernandes RM, Hartling L. Glucocorticoids for acute viral bronchiolitis in infants and young children. JAMA. 2014; 1; 311(1): 87-8. DOI: https://doi.org/10.1001/jama.2013.284921
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson DW, Klassen TP, Hartling L. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2010; 6(10): https://doi.org/10.1002/14651858.CD004878.pub3 DOI: https://doi.org/10.1002/14651858.CD004878.pub3
Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev 2014; 17-7. https://doi.org/10.1002/ebch.1988 DOI: https://doi.org/10.1002/14651858.CD009471.pub2
Philip J. The effects of inhaled corticosteroids on growth in children.Open Respir Med J 2014; 31(8): 66-73. DOI: https://doi.org/10.2174/1874306401408010066
Zhang L, Pruteanu AI, Prietsch SO, Chauhan BF, Ducharme FM. Cochrane in context: Inhaled corticosteroids in children with persistent asthma: effects on growth and dose-response effects on growth. Evid Based Child Health 2014; 9(4): 1047- 51. https://doi.org/10.1002/ebch.198 DOI: https://doi.org/10.1002/ebch.1984
Pruteanu AI, Chauhan BF, Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth. Evid Based Child Health 2014; 9(4): 931-1046. https://doi.org/10.1002/ebch.1989 DOI: https://doi.org/10.1002/ebch.1989
Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Evid Based Child Health 2014; 9(4): 829-930. https://doi.org/10.1002/ebch.1988 DOI: https://doi.org/10.1002/ebch.1988
Pruteanu AI, Chauhan BF, Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: is there a dose response impact on growth? An overview of Cochrane reviews.Paediatr Respir Rev 2015; 16(1): 51-2. https://doi.org/10.1016/j.prrv.2014.10.002 DOI: https://doi.org/10.1016/j.prrv.2014.10.002
Mener DJ, Shargorodsky J, Varadhan R, Lin SY. Topical intranasal corticosteroids and growth velocity in children: a meta-analysis. Int Forum Allergy Rhinol. 2015; 5(2): 95-103. https://doi.org/10.1002/alr.21430 DOI: https://doi.org/10.1002/alr.21430
Wijga AH1, Zuidgeest MG, Kerkhof M, Koppelman GH, Smit HA, de Jongste JC Guideline-recommended use of asthma medication by children is associated with parental information and knowledge: the PIAMA birth cohort. Pharmacoepidemiol Drug Saf. 2014; 23(4): 406-10. https://doi.org/10.1002/pds.3584 DOI: https://doi.org/10.1002/pds.3584
Napoleone E, Scasserra C. “Pharmacovigilance in Pediatric Age: The Role of Family Pediatricians- Medicines for Children Research Network (FP-MCRN)”. J Pharmacovigilance, 2015; 3(16): 3-9
Napoleone E, Lavalle A, Scasserra C, Ricci M. “Active Surveillance on the Use of Antibiotics in Children, Particularly in the Age Group from 0 to 2 Years”. J Pharmacovigilance, 2016; 4: 205 DOI: https://doi.org/10.4172/2329-6887.1000205
Napoleone E. “The appropriate use of antibiotics in early children: the FP-MCRN study”. J Develop Drugs, 5:2(Suppl), (2016): 87.
Napoleone E, Lavalle A, Scasserra C, Gentile S, Ricci M. " Improper Use of Antibiotics in Early Children Increases the risk of ADRs and Drug Resistance: the FP- MCRN Study" Cogent Medicine, 3: 1265203, (2016): 3-4
Napoleone E, Scasserra C. “ ADRs and Children: Knowledge and Methodological Standard in PASS”. Journal of Pharmacy and Pharmacology 2017; 5: 314-322 DOI: https://doi.org/10.17265/2328-2150/2017.06.003
Napoleone E, Radice S. “ From pharmacovigilance to therapy amelioration in paediatric patients: The role of the clinical pharmacologists and Family Pediatricians “. Phar. Res. 2012; 65: 168-174. https://doi.org/10.1016/j.phrs.2011.08.012 DOI: https://doi.org/10.1016/j.phrs.2011.08.012
Napoleone E., Scasserra C. et al. “Antimicrobial Stewardship in Pediatrics. Training, Prescribing and Surveillance: An Initiative in Outpatient Children”. EC Pharmacology and Toxicology 2018; 6(4): 268-276.
